Crescent Capital BDC, Inc is an asset management business based in the US. Crescent Capital BDC shares (CCAP) are listed on the NASDAQ and all prices are listed in US Dollars.
How to buy shares in Crescent Capital BDC
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – CCAP – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Crescent Capital BDC stock price (NASDAQ: CCAP)Use our graph to track the performance of CCAP stocks over time.
Crescent Capital BDC shares at a glance
|Latest market close||$18.57|
|52-week range||$10.48 - $19.52|
|50-day moving average||$18.86|
|200-day moving average||$17.58|
|Wall St. target price||$18.25|
|Dividend yield||$1.64 (8.68%)|
|Earnings per share (TTM)||$5.35|
Buy Crescent Capital BDC shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Crescent Capital BDC stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Crescent Capital BDC price performance over time
|1 week (2021-07-19)||N/A|
|1 month (2021-06-30)||-1.01%|
|3 months (2021-04-30)||1.75%|
|6 months (2021-01-26)||N/A|
|1 year (2020-07-26)||N/A|
|2 years (2019-07-26)||N/A|
|3 years (2018-07-26)||N/A|
|5 years (2016-07-26)||N/A|
Is Crescent Capital BDC under- or over-valued?
Valuing Crescent Capital BDC stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Crescent Capital BDC's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Crescent Capital BDC's P/E ratio
Crescent Capital BDC's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 3x. In other words, Crescent Capital BDC shares trade at around 3x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Crescent Capital BDC's PEG ratio
Crescent Capital BDC's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.7779. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Crescent Capital BDC's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Crescent Capital BDC financials
|Revenue TTM||$78.3 million|
|Operating margin TTM||83.73%|
|Gross profit TTM||$77.1 million|
|Return on assets TTM||4.12%|
|Return on equity TTM||29.11%|
|Market capitalisation||$525.3 million|
TTM: trailing 12 months
Shorting Crescent Capital BDC shares
There are currently 41,541 Crescent Capital BDC shares held short by investors – that's known as Crescent Capital BDC's "short interest". This figure is 89.3% up from 21,939 last month.
There are a few different ways that this level of interest in shorting Crescent Capital BDC shares can be evaluated.
Crescent Capital BDC's "short interest ratio" (SIR)
Crescent Capital BDC's "short interest ratio" (SIR) is the quantity of Crescent Capital BDC shares currently shorted divided by the average quantity of Crescent Capital BDC shares traded daily (recently around 57695.833333333). Crescent Capital BDC's SIR currently stands at 0.72. In other words for every 100,000 Crescent Capital BDC shares traded daily on the market, roughly 720 shares are currently held short.
However Crescent Capital BDC's short interest can also be evaluated against the total number of Crescent Capital BDC shares, or, against the total number of tradable Crescent Capital BDC shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Crescent Capital BDC's short interest could be expressed as 0% of the outstanding shares (for every 100,000 Crescent Capital BDC shares in existence, roughly 0 shares are currently held short) or 0.0015% of the tradable shares (for every 100,000 tradable Crescent Capital BDC shares, roughly 2 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Crescent Capital BDC.
Find out more about how you can short Crescent Capital BDC stock.
Crescent Capital BDC share dividends
Dividend payout ratio: 92.66% of net profits
Recently Crescent Capital BDC has paid out, on average, around 92.66% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 8.8% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Crescent Capital BDC shareholders could enjoy a 8.8% return on their shares, in the form of dividend payments. In Crescent Capital BDC's case, that would currently equate to about $1.64 per share.
Crescent Capital BDC's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
Crescent Capital BDC's most recent dividend payout was on 14 July 2021. The latest dividend was paid out to all shareholders who bought their shares by 28 June 2021 (the "ex-dividend date").
Crescent Capital BDC overview
Crescent Capital BDC, Inc. is a business development company. The fund focuses on originating and investing in the debt of middle market companies. It typically focuses on companies based in United States. .
Stocks similar to Crescent Capital BDC
Crescent Capital BDC in the news
LONDON BRIEFING: Reckitt shares drop at open on swing to interim loss
UK shareholder meetings calendar - next 7 days
UK shareholder meetings calendar - next 7 days
Frequently asked questionsWhat percentage of Crescent Capital BDC is owned by insiders or institutions?
Currently 16.23% of Crescent Capital BDC shares are held by insiders and 57.482% by institutions. When does the fiscal year end for Crescent Capital BDC?
Crescent Capital BDC's fiscal year ends in December. Where is Crescent Capital BDC based?
Crescent Capital BDC's address is: , United States What is Crescent Capital BDC's ISIN number?
Crescent Capital BDC's international securities identification number is: US2256551092 What is Crescent Capital BDC's CUSIP number?
Crescent Capital BDC's Committee on Uniform Securities Identification Procedures number is: 225655109
More guides on Finder
How to buy Argus Capital Corp (ARGU) stock when it goes public
Everything we know about the Argus Capital Corp IPO, plus information on how to buy in.
How to buy RenovoRx (RNXT) stock when it goes public
Everything we know about the RenovoRx IPO, plus information on how to buy in.
How to buy Draganfly (DPRO) stock when it goes public
Everything we know about the Draganfly IPO, plus information on how to buy in.
How to buy Society Pass Incorporated (SOPA) stock when it goes public
Everything we know about the Society Pass Incorporated IPO, plus information on how to buy in.
How to buy Guardforce AI Co (GFAI) stock when it goes public
Everything we know about the Guardforce AI Co IPO, plus information on how to buy in.
How to buy IsoPlexis Corporation (ISO) stock when it goes public
Everything we know about the IsoPlexis Corporation IPO, plus information on how to buy in.
How to buy Marpai (MRAI) stock when it goes public
Everything we know about the Marpai IPO, plus information on how to buy in.
How to buy DoubleDown Interactive (DDI) stock when it goes public
Everything we know about the DoubleDown Interactive IPO, plus information on how to buy in.
How to buy Omniq Corp (OMQS) stock when it goes public
Everything we know about the Omniq Corp IPO, plus information on how to buy in.
How to buy Mechanical Technology (MKTYP) stock when it goes public
Everything we know about the Mechanical Technology IPO, plus information on how to buy in.
Ask an Expert